Utah Medical Products, Inc. (UTMD)
| Market Cap | 203.94M +19.1% |
| Revenue (ttm) | 37.53M -4.4% |
| Net Income | 10.85M -16.3% |
| EPS | 3.38 -10.6% |
| Shares Out | 3.18M |
| PE Ratio | 18.88 |
| Forward PE | n/a |
| Dividend | $1.24 (1.94%) |
| Ex-Dividend Date | Jun 17, 2026 |
| Volume | 11,555 |
| Open | 63.26 |
| Previous Close | 63.82 |
| Day's Range | 62.51 - 64.27 |
| 52-Week Range | 52.00 - 71.81 |
| Beta | 0.37 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Apr 23, 2026 |
About UTMD
Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK fee... [Read more]
Financial Performance
In 2025, Utah Medical Products's revenue was $38.52 million, a decrease of -5.83% compared to the previous year's $40.90 million. Earnings were $11.29 million, a decrease of -18.65%.
Financial StatementsNews
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESS Newswire / May 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per s...
Utah Medical Products reports Q1 EPS 82c vs. 92c last year
Reports Q1 revenue $8.72M vs. $9.71M last year.
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026
SALT LAKE CITY, UT / ACCESS Newswire / April 23, 2026 / In the first calendar quarter (1Q) of 2026, Utah Medical Products, Inc. (Nasdaq:UTMD) attained financial results which were consistent with its ...
Utah Medical Products reports Q4 EPS 80c vs. 86c last year
Reports Q4 revenue $9.04M vs. $9.16M last year.
Utah Medical Products raises quarterly cash dividend 1.6% to 31c per share
Utah Medical Products (UTMD) announces that its board of directors has appointed Kevin C. Timken, Esq to its board. In addition, the board approved a quarterly cash dividend of 31c…
Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend
SALT LAKE CITY, UT / ACCESS Newswire / November 4, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Kevin C. Timken, Esq to its Board of Directors.
Utah Medical Products reports Q3 EPS 82c vs. $1.03 last year
Reports Q3 revenue $9.8M vs. $10M last year.
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2025
SALT LAKE CITY, UT / ACCESS Newswire / October 23, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2025 financial results that w...
Utah Medical Products reports Q2 EPS 94c vs. 98c last year
Reports Q2 revenue $9,953 vs. $10,400 last year.
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2025
SALT LAKE CITY, UT / ACCESS Newswire / July 24, 2025 / Utah Medical Products, Inc. [Nasdaq:UTMD] reports second calendar quarter (2Q) and first half (1H) 2025 financial results which are consistent wi...
Utah Medical Products reports Q1 EPS 92c vs. $1.09 last year
Reports Q1 revenue $9.7M vs. $11.3M last year.
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2025
SALT LAKE CITY, UT / ACCESS Newswire / April 29, 2025 / In the first calendar quarter (1Q) of 2025, Utah Medical Products, Inc. (Nasdaq:UTMD) attained financial results consistent with its previously ...
Utah Medical Products reports Q4 EPS 85.7c vs. $1.18 last year
Reports Q4 revenue $9.2M vs. $12.3M last year.
UTMD Reports Year 2024 and Fourth Quarter Financial Performance
SALT LAKE CITY, UT / ACCESS Newswire / January 28, 2025 / With Revenues 19% lower, Net Income 17% lower and Earnings Per Share (EPS) 13% lower than in 2023, Utah Medical Products, Inc. (NASDAQ:UTMD) c...
Utah Medical Products appoints Carrie Leigh to board of directors
Utah Medical Products (UTMD) announces that its Board of Directors has appointed Carrie Leigh to its Board of Directors. Ms. Leigh, who was employed in direct sales positions for UTMD…
Utah Medical Products reports Q3 EPS $1.025 vs. $1.081 last year
Reports Q3 revenue $10M vs. $12.5M last year.
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024
SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2024 financial results that were w...
Utah Medical Products reports Q2 EPS 97.8c vs. $1.154 last year
Reports Q2 revenue $10.4M vs. $12.9M last year
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024
SALT LAKE CITY, UT / ACCESSWIRE / July 25, 2024 / As previously projected, Utah Medical Products, Inc. (Nasdaq:UTMD) realized second calendar quarter (2Q) and first half (1H) 2024 financial results wh...
Utah Medical Products reports Q1 EPS $1.09 vs. $1.16 last year
Reports Q1 revenue $11.3M vs. $12.5M last year.
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024
SALT LAKE CITY, UT / ACCESSWIRE / April 25, 2024 / In the first calendar quarter (1Q) of 2024, Utah Medical Products, Inc. (NASDAQ:UTMD) attained financial results consistent with its previously annou...
Utah Medical Products reports Q4 EPS $1.18 vs. $1.25 last year
Reports Q4 revenue $12.3M vs. $13.6M last year
UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
SALT LAKE CITY, UT, Jan. 30, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – With Revenues 4% lower and Net Income and Earnings Per Share 1% higher than in 2022, Utah Medical Products, Inc. (Nasdaq: UTMD)...
Utah Medical Products announces 1.7% increase in dividend to 30c per share
Utah Medical Products announces that its board of directors approved a quarterly cash dividend of 30c per share of common stock payable on January 3, 2024 to shareholders of record…
Utah Medical Products, Inc. Increases Regular Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / October 31, 2023 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share...